132 related articles for article (PubMed ID: 21883437)
1. Validation of a single-sample urinary C-peptide creatinine ratio as a reproducible alternative to serum C-peptide in patients with Type 2 diabetes.
Bowman P; McDonald TJ; Shields BM; Knight BA; Hattersley AT
Diabet Med; 2012 Jan; 29(1):90-3. PubMed ID: 21883437
[TBL] [Abstract][Full Text] [Related]
2. Urine C-peptide creatinine ratio is an alternative to stimulated serum C-peptide measurement in late-onset, insulin-treated diabetes.
Jones AG; Besser RE; McDonald TJ; Shields BM; Hope SV; Bowman P; Oram RA; Knight BA; Hattersley AT
Diabet Med; 2011 Sep; 28(9):1034-8. PubMed ID: 21843301
[TBL] [Abstract][Full Text] [Related]
3. Stability and reproducibility of a single-sample urinary C-peptide/creatinine ratio and its correlation with 24-h urinary C-peptide.
McDonald TJ; Knight BA; Shields BM; Bowman P; Salzmann MB; Hattersley AT
Clin Chem; 2009 Nov; 55(11):2035-9. PubMed ID: 19713273
[TBL] [Abstract][Full Text] [Related]
4. Stimulated urine C-peptide creatinine ratio vs serum C-peptide level for monitoring of β-cell function in the first year after diagnosis of Type 1 diabetes.
Tatovic D; Luzio S; Dunseath G; Liu Y; Alhadj Ali M; Peakman M; Dayan CM;
Diabet Med; 2016 Nov; 33(11):1564-1568. PubMed ID: 27425010
[TBL] [Abstract][Full Text] [Related]
5. Urinary C-peptide creatinine ratio detects absolute insulin deficiency in Type 2 diabetes.
Hope SV; Jones AG; Goodchild E; Shepherd M; Besser RE; Shields B; McDonald T; Knight BA; Hattersley A
Diabet Med; 2013 Nov; 30(11):1342-8. PubMed ID: 23659458
[TBL] [Abstract][Full Text] [Related]
6. Urinary C-peptide creatinine ratio to differentiate type 2 diabetes mellitus from type 1 in pediatric patients.
Elzahar W; Arafa A; Youssef A; Erfan A; El Amrousy D
Eur J Pediatr; 2020 Jul; 179(7):1115-1120. PubMed ID: 32052124
[TBL] [Abstract][Full Text] [Related]
7. Variation of endogenous insulin secretion in association with treatment status: assessment by serum C-peptide and modified urinary C-peptide.
Aoki Y
Diabetes Res Clin Pract; 1991 Dec; 14(3):165-73. PubMed ID: 1778109
[TBL] [Abstract][Full Text] [Related]
8. Clinical Implications of Urinary C-Peptide Creatinine Ratio in Patients with Different Types of Diabetes.
Wang Y; Gao Y; Cai X; Chen L; Zhou L; Ma Y; Gong S; Han X; Ji L
J Diabetes Res; 2019; 2019():1747684. PubMed ID: 31485449
[TBL] [Abstract][Full Text] [Related]
9. Serum bilirubin concentrations are positively associated with serum C-peptide levels in patients with Type 2 diabetes.
Chung JO; Cho DH; Chung DJ; Chung MY
Diabet Med; 2014 Nov; 31(11):1316-22. PubMed ID: 24910105
[TBL] [Abstract][Full Text] [Related]
10. Reproducibility of beta-cell function estimates in non-insulin-dependent diabetes mellitus.
Gjessing HJ; Damsgaard EM; Matzen LE; Frøland A; Faber OK
Diabetes Care; 1987; 10(5):558-62. PubMed ID: 3315512
[TBL] [Abstract][Full Text] [Related]
11. Fasting plasma C-peptide, glucagon stimulated plasma C-peptide, and urinary C-peptide in relation to clinical type of diabetes.
Gjessing HJ; Matzen LE; Faber OK; Frøland A
Diabetologia; 1989 May; 32(5):305-11. PubMed ID: 2666217
[TBL] [Abstract][Full Text] [Related]
12. Reevaluation of urine C-peptide as measure of insulin secretion.
Tillil H; Shapiro ET; Given BD; Rue P; Rubenstein AH; Galloway JA; Polonsky KS
Diabetes; 1988 Sep; 37(9):1195-201. PubMed ID: 3044885
[TBL] [Abstract][Full Text] [Related]
13. The association between postprandial urinary C-peptide creatinine ratio and the treatment response to liraglutide: a multi-centre observational study.
Thong KY; McDonald TJ; Hattersley AT; Blann AD; Ramtoola S; Duncan C; Carr S; Adamson K; Nayak AU; Khurana R; Hunter SJ; Ali A; Au S; Ryder RE
Diabet Med; 2014 Apr; 31(4):403-11. PubMed ID: 24246138
[TBL] [Abstract][Full Text] [Related]
14. Urinary C-Peptide/Creatinine Ratio Can Distinguish Maturity-Onset Diabetes of the Young from Type 1 Diabetes in Children and Adolescents: A Single-Center Experience.
Yılmaz Agladioglu S; Sagsak E; Aycan Z
Horm Res Paediatr; 2015; 84(1):54-61. PubMed ID: 25792383
[TBL] [Abstract][Full Text] [Related]
15. Urinary C-peptide analysis in an intervention study: experience from the DEFEND-2 otelixizumab trial.
Ambery P; Donaldson J; Parkin J; Austin DJ
Diabet Med; 2016 Nov; 33(11):1559-1563. PubMed ID: 26871270
[TBL] [Abstract][Full Text] [Related]
16. Contribution of hyperglycemia and renal damage to urinary C-peptide clearance in non-insulin-dependent diabetic patients.
Aoki Y; Yanagisawa Y; Oguchi H; Furuta S
Diabetes Res Clin Pract; 1991 Nov; 14(2):85-9. PubMed ID: 1756686
[TBL] [Abstract][Full Text] [Related]
17. Post-glucose-load urinary C-peptide and glucose concentration obtained during OGTT do not affect oral minimal model-based plasma indices.
Jainandunsing S; Wattimena JL; Rietveld T; van Miert JN; Sijbrands EJ; de Rooij FW
Endocrine; 2016 May; 52(2):253-62. PubMed ID: 26526605
[TBL] [Abstract][Full Text] [Related]
18. Urine C-peptide creatinine ratio is a noninvasive alternative to the mixed-meal tolerance test in children and adults with type 1 diabetes.
Besser RE; Ludvigsson J; Jones AG; McDonald TJ; Shields BM; Knight BA; Hattersley AT
Diabetes Care; 2011 Mar; 34(3):607-9. PubMed ID: 21285386
[TBL] [Abstract][Full Text] [Related]
19. Comparison of cystatin C- and creatinine-based estimated glomerular filtration rate to predict coronary heart disease risk in Japanese patients with obesity and diabetes.
Ito R; Yamakage H; Kotani K; Wada H; Otani S; Yonezawa K; Ogo A; Okajima T; Adachi M; Araki R; Yoshida K; Saito M; Nagaoka T; Toyonaga T; Tanaka T; Yamada T; Ota I; Oishi M; Miyanaga F; Shimatsu A; Satoh-Asahara N;
Endocr J; 2015; 62(2):201-7. PubMed ID: 25399862
[TBL] [Abstract][Full Text] [Related]
20. Markers of Glomerular and Tubular Damage in the Early Stage of Kidney Disease in Type 2 Diabetic Patients.
Żyłka A; Dumnicka P; Kuśnierz-Cabala B; Gala-Błądzińska A; Ceranowicz P; Kucharz J; Ząbek-Adamska A; Maziarz B; Drożdż R; Kuźniewski M
Mediators Inflamm; 2018; 2018():7659243. PubMed ID: 30158836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
